TOLVAPTAN News
TOLVAPTAN currently has 0 news articles, with 13 predicted indications.
This page combines the AI-predicted indications for TOLVAPTAN with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (13):
- inappropriate ADH syndrome (99.0%)
- nephrogenic syndrome of inappropriate antidiuresis (99.0%)
- polycystic kidney disease (99.0%)
- polycystic kidney disease 3 with or without polycystic liver disease (100.0%)
- renal-hepatic-pancreatic dysplasia (100.0%)
- karyomegalic interstitial nephritis (100.0%)
- thoracic malformation (100.0%)
- Joubert syndrome with renal defect (100.0%)
- adult familial nephronophthisis-spastic quadriparesia syndrome (100.0%)
- Ambras type hypertrichosis universalis congenita (100.0%)
- hypertrichosis (disease) (100.0%)
- malformation syndrome with odontal and/or periodontal component (100.0%)
- syndrome with a Dandy-Walker malformation as major feature (100.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.